About Oncorena

Oncorena is a pharmaceutical company that is working on a treatment for advanced kidney cancer (metastatic renal cancer). Its goal is to confirm orellanine's potent anti-tumor activity and other clinical benefits in patients with advanced kidney cancer.

Company Highlights
Year Founded

2011

icon-altEmployees

11

Location (HQ)

SWE

Since Last Funding

2 years 8 months

icon-altTotal Investment Amt

$8.9M

Last Funding Round

Series Unknown

icon-altYoY Headcount Growth

9.9%

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Health Care

Pharmaceutical Manufacturing

Therapeutics